Evolent Health Inc
* Amendment to definition of “merger consideration” to be cash in amount of $50.3 million,7.42 million shares of co’s Class A common stock
* Amendment to reflect decrease in amount of additional contingent share consideration payable under certain conditions to $12.38 million
* On Oct 3, co, unit entered into amendment to merger deal dated July 12, 2016, by and among co, Valence Health, Inc – SEC filing
* After giving effect to amendment, aggregate amount of merger consideration to be paid by the co at closing is $219.4 million Source text for Eikon: Further company coverage:
Recent Articles on M&A
Source: Reuters.com
